APG
SGMT icon

Abacus Planning Group’s Sagimet Biosciences SGMT Stock Holding History

Abacus Planning Group’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$140K Hold
18,064
– – 0.02% 253
2026
Q1 		$94.4K Sell
18,064
-11,904
-40% -$66.3K 0.01% 260
2025
Q4 		$177K Hold
29,968
– – 0.02% 255
2025
Q3 		$206K Hold
29,968
– – 0.03% 238
2025
Q2 		$228K Buy
29,968
+3,819
+15% +$16.1K 0.03% 215
2025
Q1 		$85.2K Buy
+26,149
New +$110K 0.01% 230

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Abacus Planning Group's SGMT Position: Q2 2026 in Review

Abacus Planning Group held its Sagimet Biosciences (SGMT) position steady in Q2 2026 at 18,064 shares worth $140K. The position accounts for 0.02% of the portfolio, ranked #253.

Abacus Planning Group first reported a position in SGMT in Q1 2025 and has held it in 6 quarters since. The position peaked at $228K in Q2 2025. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • Abacus Planning Group held 18,064 shares of Sagimet Biosciences worth $140K as of Q2 2026.
  • Abacus Planning Group left its Sagimet Biosciences share count unchanged in Q2 2026.
  • Sagimet Biosciences made up 0.02% of Abacus Planning Group's portfolio in Q2 2026, its #253 holding.
  • Abacus Planning Group first reported a position in Sagimet Biosciences in Q1 2025 and has held it in 6 quarters since.
  • Abacus Planning Group's Sagimet Biosciences position peaked at $228K in Q2 2025.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Abacus Planning Group's 13F filing for Q2 2026, filed 20 Jul 2026.